Resolution of Expression of Concern: Machine Learning Approaches for Predicting Breast Cancer Recurrence: A Comparative Analysis
Main Article Content
Abstract
Resolution of Expression of Concern regarding for: Machine Learning Approaches for Predicting Breast Cancer Recurrence: A Comparative Analysis (N. R. . Abbas, H. . Alkattan, & I. B. . Aldallal , Trans.). (2025). Mesopotamian Journal of Artificial Intelligence in Healthcare, 2025, 208-218.
https://doi.org/10.58496/MJAIH/2025/020
DOI of this Notice: https://doi.org/10.58496/MJAIH/2026/012
Original Article: https://doi.org/10.58496/MJAIH/2025/020
Expression of Concern: https://doi.org/10.58496/MJAIH/2026/010
Following the publication of the article, Machine Learning Approaches for Predicting Breast Cancer Recurrence: A Comparative Analysis
Published 2025-07-30 an Expression of Concern was issued by the Mesopotamian Journal of Artificial Intelligence in Healthcare on 2026-03-05 to alert our readers to concerns regarding methodology, data provenance, and reported outcomes to confirm their reliability and reproducibility
The editorial team of the Mesopotamian Journal of Artificial Intelligence in Healthcare has completed a thorough post-publication review of the article, the supporting data, and the authors' responses to the queries raised.
Upon careful assessment, we have determined that the concerns have been addressed and clarified to the satisfaction of the editors. We have found no evidence of misconduct or invalidity in the research. The findings presented in the original article are considered robust and accurate.
This notice formally resolves the previously published Expression of Concern. The original article stands as published, and we affirm the integrity of the research.
The Mesopotamian Journal of Artificial Intelligence in Healthcare thanks the readers who brought these matters to our attention, as well as the authors for their cooperation during the review process.
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.